Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303
- Citation:
- J. Clin. Oncol vol 37 (21) 1790-1799
- Year:
- 2019
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Previous presentation of the manuscript; American Society of Hematology Annual Meeting, December 2016
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 8
- Parents:
- 2569
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U10CA180847, U10CA180833, U10CA180799, U10CA180820, U24CA196171
- Corr. Author:
- Authors:
- Nancy L. Bartlett Wyndham H. Wilson Sin-Ho Jung Eric D. Hsi Matthew J. Maurer Levi D. Pederson Mei-Yin C. Polley Brandelyn N. Pitcher Bruce D. Cheson Brad S. Kahl Jonathan W. Friedberg Louis M. Staudt Nina D. Wagner-Johnston Kristie A. Blum Jeremy S. Abramson Nishitha M. Reddy Jane N. Winter Julie E. Chang Ajay K. Gopal Amy Chadburn Susan Mathew Richard I. Fisher Kristy L. Richards Heiko Schöder Andrew D. Zelenetz John P. Leonard
- Networks:
- CAPITAL, CORA, LAPS-IL036, LAPS-MA036, LAPS-MD017, LAPS-MN026, LAPS-MO011, LAPS-NY016, LAPS-OH007, LAPS-TN008, LAPS-WI020, NY018, PA121
- Study
- CALGB-50303
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- RAPID COMMUNICATION, Lymphoma and Myeloma